A “Double-Locked” and Enzyme/pH-Activated Theranostic Agent for Accurate Tumor Imaging and Therapy

Theranostic agents for concurrent cancer therapy and diagnosis have begun attracting attention as a promising modality. However, accurate imaging and identification remains a great challenge for theranostic agents. Here, we designed and synthesized a novel theranostic agent H6M based on the “double-...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jia, Guan, Zongyu, Gao, Weijie, Wang, Chen, Xu, Zhongyuan, Meng, Chi, Liu, Yun, Zhang, Yuquan, Guo, Qingsong, Ling, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779152/
https://www.ncbi.nlm.nih.gov/pubmed/35056740
http://dx.doi.org/10.3390/molecules27020425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779152/
https://www.ncbi.nlm.nih.gov/pubmed/35056740
http://dx.doi.org/10.3390/molecules27020425

Ejemplares similares